DEF 14A Filing

Company

Enveric Biosciences, Inc.

Filed

July 16, 2018

Period of Report

June 29, 2018

Accession Number

0000921895-18-002107

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →